Parallax Volatility Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Buy
98,200
+15,600
+19% +$1.95M 0.03% 333
2025
Q4
$10.1M Sell
82,600
-19,400
-19% -$2.22M 0.02% 458
2025
Q3
$10.2M Sell
102,000
-22,200
-18% -$2M 0.02% 457
2025
Q2
$10.3M Sell
124,200
-11,900
-9% -$949K 0.02% 421
2025
Q1
$11M Sell
136,100
-1,575,100
-92% -$141M 0.03% 435
2024
Q4
$154M Buy
1,711,200
+218,900
+15% +$21.2M 0.3% 63
2024
Q3
$147M Sell
1,492,300
-132,300
-8% -$13M 0.27% 66
2024
Q2
$151M Buy
1,624,600
+1,305,300
+409% +$117M 0.32% 50
2024
Q1
$30.3M Sell
319,300
-373,100
-54% -$34.6M 0.07% 230
2023
Q4
$61.8M Buy
692,400
+330,500
+91% +$24.5M 0.13% 151
2023
Q3
$26.4M Sell
361,900
-135,000
-27% -$10.8M 0.06% 253
2023
Q2
$41.3M Sell
496,900
-82,500
-14% -$6.9M 0.09% 190
2023
Q1
$44.2M Sell
579,400
-70,100
-11% -$5.82M 0.09% 215
2022
Q4
$53.9M Sell
649,500
-3,300
-0.5% -$267K 0.08% 263
2022
Q3
$51.8M Sell
652,800
-41,500
-6% -$3.5M 0.08% 267
2022
Q2
$51.6M Sell
694,300
-48,700
-7% -$3.66M 0.05% 262
2022
Q1
$66.8M Sell
743,000
-121,200
-14% -$11.2M 0.03% 211
2021
Q4
$96.8M Buy
864,200
+61,300
+8% +$7.39M 0.11% 124
2021
Q3
$101M Buy
802,900
+90,800
+13% +$11.7M 0.1% 153
2021
Q2
$96.4M Sell
712,100
-161,700
-19% -$21.3M 0.13% 110
2021
Q1
$119M Sell
873,800
-400,700
-31% -$60M 0.26% 57
2020
Q4
$179M Sell
1,274,500
-145,400
-10% -$18.6M 0.18% 88
2020
Q3
$158M Sell
1,419,900
-14,500
-1% -$1.63M 0.12% 143
2020
Q2
$161M Buy
1,434,400
+633,000
+79% +$62.3M 0.19% 79
2020
Q1
$62.1M Buy
801,400
+282,300
+54% +$25M 0.08% 177
2019
Q4
$49.4M Buy
519,100
+73,800
+17% +$6.38M 0.06% 215
2019
Q3
$34M Sell
445,300
-127,500
-22% -$10.6M 0.04% 253
2019
Q2
$50.2M Sell
572,800
-919,700
-62% -$78.4M 0.05% 178
2019
Q1
$135M Sell
1,492,500
-33,200
-2% -$2.82M 0.15% 66
2018
Q4
$109M Buy
1,525,700
+1,086,600
+247% +$87.5M 0.14% 108
2018
Q3
$42.1M Sell
439,100
-514,800
-54% -$49.9M 0.05% 164
2018
Q2
$90.8M Sell
953,900
-413,600
-30% -$38M 0.13% 74
2018
Q1
$120M Buy
1,367,500
+387,000
+39% +$35.3M 0.16% 67
2017
Q4
$83.2M Buy
980,500
+748,000
+322% +$62.7M 0.11% 84
2017
Q3
$20.1M Buy
232,500
+26,500
+13% +$2.12M 0.03% 267
2017
Q2
$15.9M Sell
206,000
-501,700
-71% -$35.6M 0.03% 296
2017
Q1
$49.1M Buy
707,700
+96,700
+16% +$6.49M 0.1% 126
2016
Q4
$36.2M Sell
611,000
-271,500
-31% -$16.8M 0.07% 190
2016
Q3
$58.5M Sell
882,500
-220,900
-20% -$13.7M 0.11% 126
2016
Q2
$59.7M Sell
1,103,400
-581,200
-35% -$31.8M 0.12% 109
2016
Q1
$87M Buy
1,684,600
+1,584,600
+1,585% +$82.3M 0.19% 71
2015
Q4
$7.02M Sell
100,000
-36,500
-27% -$2.49M 0.01% 563
2015
Q3
$8.5M Sell
136,500
-418,500
-75% -$33M 0.02% 502
2015
Q2
$46.7M Buy
+555,000
New +$43.2M 0.1% 132
2014
Q3
Sell
-2,100
Closed -$107K 4555
2014
Q2
$107K Buy
+2,100
New +$94.7K ﹤0.01% 2447
2013
Q4
Sell
-600
Closed -$26K 3624
2013
Q3
$26K Buy
+600
New +$24.3K ﹤0.01% 2145

Other funds holding XBI